Not logged in.png)
Share.png)
SavePhase III Study Investigating the Safety and Efficacy of TM5614 in Combination With Nivolumab for the Treatment of Unresectable Malignant Melanoma: Protocol
Fujimura, Taku; Yoshino, Koji; Kato, Hiroshi; Fukushima, Satoshi; Fujisawa, Yasuhiro; Matsushita, Shigeto; Uhara, Hisashi; Rokunohe, Daiki; Takenouchi, Tatsuya; Maekawa, Takeo; Nakamura, Yoshiyuki; Namikawa, Kenjiro; Takahashi, Akira; Yoshikawa, Shusuke; Iwata, Hiroaki; Yamasaki, Osamu; Uchi, Hiroshi; Ohno, Fumitaka; Ito, Takamichi; Tanemura, Atsushi; Ohe, Shuichi; Yamazaki, Emi; Takahashi-watanabe, Manami; Muto, Yusuke; Kambayashi, Yumi; Hashimoto, Akira; Asano, Yoshihide Share Save Share Save Real-World Efficacy of Chemotherapy in Patients With Advanced Unresectable Extramammary Paget Disease: A Retrospective Multicenter Study of 138 Japanese PatientsMiyashita, Azusa; Fukushima, Satoshi; Yoshino, Koji; Kato, Hiroshi; Yamazaki, Naoya; Kawashima, Shusuke; Yamamoto, Yuki; Nakamura, Yasuhiro; Kiniwa, Yukiko; Ishizuki, Shoichiro; Maekawa, Takeo; Okada, Etsuko; Fujimura, Taku; Fujii, Kazuyasu; Fujisawa, Yasuhiro; Asai, Jun; Otsuka, Atsushi; Kajihara, Ikko; Morinaga, Jun; Matsushita, Shigeto Share Save Share Save Share Save Share Save Share Save Share Save Share Save Share Save Share Save The genetic evolution of acral melanomaWang, Meng; Fukushima, Satoshi; Sheen, Yi-Shuan; Ramelyte, Egle; Cruz-Pacheco, Noel; Shi, Chenxu; Liu, Shanshan; Banik, Ishani; Aquino, Jamie D.; Acosta, Martin Sangueza; Levesque, Mitchell; Dummer, Reinhard; Liau, Jau-Yu; Chu, Chia-Yu; Shain, A. Hunter; Yeh, Iwei; Bastian, Boris C. Share Save Evaluation of the associations of interlukin-7 genetic variants with toxicity and efficacy of immune checkpoint inhibitors: A replication study of a Japanese population, based on the findings of a European genome-wide association studyMiyamoto, Hideaki; Kondo, Yasuteru; Itobayashi, Ei; Uehara, Masayoshi; Hiraoka, Atsushi; Kudo, Masatoshi; Kakizaki, Satoru; Kagawa, Tatehiro; Miuma, Satoshi; Suzuki, Takanori; Sugi, Kazuhiro; Suyama, Koichi; Beppu, Toru; Toyoda, Hidenori; Yoshiji, Hitoshi; Uojima, Haruki; Miyase, Shiho; Inoue, Kaori; Tamori, Akihiro; Ito, Takanori; Shimose, Shigeo; Suda, Goki; Hayashi, Tsuguru; Onishi, Masaya; Narahara, Satoshi; Watanabe, Takehisa; Iwatsuki, Masaaki; Fukushima, Satoshi; Tanaka, Yasuhito Share Save A phase II multicentre study of plasminogen activator inhibitor-1 inhibitor (TM5614) plus nivolumab for treating anti-programmed cell death 1 antibody-refractory malignant melanoma: TM5614-MM trialFujimura, Taku; Yoshino, Koji; Kato, Hiroshi; Fukushima, Satoshi; Ishizuki, Shoichiro; Otsuka, Atsushi; Matsushita, Shigeto; Amagai, Ryo; Muto, Yusuke; Yamazaki, Emi; Kambayashi, Yumi; Yahata, Takashi; Miyata, Toshio; Fujisawa, Yasuhiro; Asano, Yoshihide Share Save Share Save Share Save 
.png){kind=icon}
.png){kind=icon}
.png){kind=icon}
.png){kind=icon}
.png){kind=icon}
